CBRE Group shares worth $316K listed for sale

CBRE Group, Inc. (CBRE) lists 2,250 Class A shares for sale, with an aggregate market value of $315,967.50 and an approximate sale date of November 4, 2026.

Available on EDGAR 11/04/2026 - 11:23 AM EST Accepted by SEC EDGAR 11/04/2026 - 11:22 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CBRE Group, Inc. (CBRE) lists 2,250 Class A shares for sale, with an aggregate market value of $315,967.50 and an approximate sale date of November 4, 2026. Fidelity Brokerage Services LLC is named as broker. Robert E. Sulentic, identified as an officer and director, is named for the account; the remarks say today's sale took place in the Sulentic Family Foundation, where he is an authorized individual.

Key Figures

Shares listed for sale: 2,250 shares Aggregate market value: $315,967.50 Shares outstanding: 288,196,254 shares +1 more

4 metrics

Shares listed for sale 2,250 shares Class A

Aggregate market value $315,967.50 Shares listed for sale

Shares outstanding 288,196,254 shares Share count shown in the sale notice

Approximate sale date November 4, 2026 Date listed for the sale

Key Terms

Rule 144, Restricted Stock Vesting, authorized individual

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

authorized individual regulatory

"Robert E. Sulentic is an authorized individual"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CBRE shares are listed for sale by Robert E. Sulentic?

The notice lists 2,250 Class A shares, with an aggregate market value of $315,967.50 and an approximate sale date of November 4, 2026. Robert E. Sulentic is named for the account, while the remarks say today's sale took place in the Sulentic Family Foundation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001190868
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CBRE GROUP, INC.
SEC File Number	001-32205
Address of Issuer	2121 NORTH PEARL STREET SUITE 300 DALLAS TEXAS 75201
Phone	214-979-6100
Name of Person for Whose Account the Securities are To Be Sold	SULENTIC ROBERT E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2250	315967.50	288196254	11/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/05/2014	Restricted Stock Vesting	Issuer			2250	09/05/2014	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Today's sale took place in the Sulentic Family Foundation in which Robert E. Sulentic is an authorized individual.
Date of Notice	11/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert E Sulentic
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)